Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram
Purpose
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer
Real-world treatment and survival in early-stage NSCLC - Medical Conferences
Overall survival rates of patients with lung cancer. Kaplan-Meier... | Download Scientific Diagram
Education & Resources for Oncology Nurses – IMFINZI® (durvalumab)
Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
Non-Small Cell Lung Cancer
Surgery soon after clinical staging of non-sm | EurekAlert!
Kaplan-Meier survival analyses of overall survival (A) and lung... | Download Scientific Diagram
VA Studies Provide Insight Into Improving Survival in Small Cell Lung Cancer - U.S. Medicine
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text
Overall survival curves of patients with lung cancer. The 5-year... | Download Scientific Diagram
REVEL Trial Overall Survival for | CYRAMZA® (ramucirumab)
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
Stereotactic ablative radiotherapy shows long-term benefit in operable early NSCLC
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer | NEJM
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - ScienceDirect
Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society
Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection | In Vivo
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
